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This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).SUMMARYStandardization of mesenchymal stromal cells (MSCs) remains a major obstacle in regenerative medicine. Starting material and culture
expansion affect cell preparations and render comparison between studies difficult. In contrast, induced pluripotent stem cells (iPSCs)
assimilate toward a ground state andmay therefore give rise to more standardized cell preparations. We reprogrammedMSCs into iPSCs,
which were subsequently redifferentiated toward MSCs. These iPS-MSCs revealed similar morphology, immunophenotype, in vitro
differentiation potential, and gene expression profiles as primary MSCs. However, iPS-MSCs were impaired in suppressing T cell prolif-
eration. DNA methylation (DNAm) profiles of iPSCs maintained donor-specific characteristics, whereas tissue-specific, senescence-asso-
ciated, and age-related DNAm patterns were erased during reprogramming. iPS-MSCs reacquired senescence-associated DNAm during
culture expansion, but they remained rejuvenated with regard to age-related DNAm. Overall, iPS-MSCs are similar to MSCs, but they
reveal incomplete reacquisition of immunomodulatory function andMSC-specificDNAmpatterns—particularly of DNAmpatterns asso-
ciated with tissue type and aging.INTRODUCTION
Mesenchymal stromal cells (MSCs) are heterogeneous cell
preparations and only a small subpopulation often referred
to as ‘‘mesenchymal stem cells’’ possesses multilineage dif-
ferentiation potential (Dominici et al., 2006).MSCprepara-
tions are greatly affected by starting material, such as bone
marrow (BM) or adipose tissue (AT), and cell-culturemedia.
Furthermore, they acquire functional changes during cul-
ture expansion ending in replicative senescence (Wagner
and Ho, 2007). So far, MSCs are scarcely defined by fibro-
blastoid plastic adherent growth, a panel of nonspecific
surface markers, and their capacity to differentiate toward
adipogenic, osteogenic, and chondrogenic lineages (Dom-
inici et al., 2006).
In this regard, induced pluripotent stem cells (iPSCs)
converge to a better-defined ground state of pluripotency
(Hackett et al., 2013). They can be differentiated into all
cell types of the organism and—while in pluripotent
state—cultured virtually indefinitely without signs of
replicative senescence. Epigenetic profiles, such as DNA
methylation (DNAm) patterns, are reorganized during re-
programming of somatic cells into iPSCs and closely
resemble those of embryonic stem cells (ESCs) (Huang
et al., 2014). In particular, senescence-associated DNAm,
which is acquired during in vitro expansion (Koch et al.,
2013), and age-related DNAm, which accumulate during414 Stem Cell Reports j Vol. 3 j 414–422 j September 9, 2014 j ª2014 The Aaging of the organism (Horvath, 2013), are reversed to
ground state. In comparison to primary cells, iPSCs are
therefore better defined and offer a good starting point
for large-scale generation of standardized derivatives,
such as iPSC-derived MSCs (iPS-MSCs).
Several groups described strategies to derive MSC-like
cells from either ESCs (Barberi et al., 2005; Boyd et al.,
2009) or iPSCs (Liu et al., 2012; Diederichs and Tuan,
2014; Zhang et al., 2011). These approaches were based
on coculture with primary MSCs, growth factor combina-
tions, or spontaneous differentiation in embryoid bodies
(EBs). So far, it has not been analyzed whether DNAm pat-
terns of iPS-MSCs resemble those of primary MSCs.RESULTS
Redifferentiation of iPSCs toward iPS-MSCs
We have recently reprogrammed MSCs from human bone
marrow into iPSCs (Shao et al., 2013). These iPSCs were
now redifferentiated toward iPS-MSCs using two alterna-
tive protocols: (1) the culture medium was simply
exchanged to initial MSC-culture medium that comprised
10% human platelet lysate (hPL) or (2) iPSCs were allowed
initially to differentiate into EBs in ultralow attachment
plates for 7 days in differentiation medium (Figure S1A
available online). Thereafter, cells were cultured underuthors
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DNA Methylation in iPS-MSCsstandard culture conditions for MSCs with 10% hPL. After
35 days (four passages), the cells revealed a typical fibroblas-
toid growth pattern; these cells are referred to as iPS-MSCs
in this manuscript (Figure 1A). iPS-MSCs passaged on
gelatin-coated (Figure 1B) or noncoated (Figure S1B) tissue
culture plastic exhibited significantly higher proliferation
rates than primary MSCs of the corresponding passage.
The immunophenotype of iPS-MSCs was essentially iden-
tical to primary MSCs (CD29+, CD73+, CD90+, CD105+,
CD14, CD31, CD34, and CD45), albeit CD105 was
less expressed in iPS-MSCs (Figures 1C and S1C). Further-
more, differentiation of iPS-MSCs toward osteogenic and
chondrogenic lineage was equivalent to MSCs. Adipogenic
differentiation was also induced in iPS-MSCs, although
accumulation of lipid droplets was less pronounced than
in primary MSCs (Figures 1D and S1D). These results on
in vitro differentiation potential were further validated by
upregulation of lineage-specific marker genes (Figure 1E).
Taken together, iPS-MSCs fulfilled the minimal criteria for
definition of MSCs (Dominici et al., 2006) - even though
less prone to adipogenic differentiation. Because both redif-
ferentiation protocols (with or without EB formation) did
not reveal significant differences, we used the one-step dif-
ferentiation protocol without EB formation and with
gelatin coating for subsequent experiments.
iPS-MSCs Reveal Similar Gene Expression as MSCs
Global gene expression was compared in MSCs, iPSCs, and
iPS-MSCs. Hierarchical cluster analysis revealed close rela-
tionship between iPS-MSCs and MSCs (Figure 2A), which
was confirmed by pairwise correlation coefficients (Fig-
ure 2B). Gradual changes in gene expression were already
observed during the first week of differentiation (Table
S1): MSC marker genes including ecto-50-nucleotidase
(NT5E; CD73), CD44 antigen (CD44), alanyl aminopepti-
dase (ANPEP; CD13), and neural cell adhesion molecule 1
(NCAM1; CD56) were already upregulated. On the other
hand, pluripotency genes were rapidly downregulated
upon differentiation toward iPS-MSCs (Figures 2C, S2A,
and S2B). Mesodermal genes typically expressed in MSCs
were expressed at a similar level in iPS-MSCs (Figure 2D).
Pairwise comparison of gene expression in MSCs, iPSCs,
and iPS-MSCs revealed relatively few significantly differen-
tially expressed genes between MSCs and iPS-MSCs (2-fold
differential expression and adjusted p value <0.01; Fig-
ure 2E; Table S2): 339 genes were higher expressed in iPS-
MSCs, and these were particularly enriched in gene
ontology (GO) categories of transcriptional regulation,
cell adhesion, and development; 214 genes were higher
expressed in MSCs that were particularly enriched in GO
categories for T cell activation and immune response (Fig-
ure 2F). Therefore, we used a surrogate assay to determine
suppression of T cell proliferation in coculture with iPS-Stem CellMSCs or MSCs. Indeed, MSCs significantly suppressed
T cell proliferation in a dose-dependent manner, whereas
this was not observed in iPS-MSCs, indicating lower immu-
nomodulatory function (Figure 2G). To further classify
gene expression profiles of iPS-MSCs, we used PhysioSpace
analysis, a bioinformatics tool to interpret gene expression
differences between two distinct cell types in terms of phys-
iologically relevant expression patterns (Lenz et al., 2013)
that provided further evidence that iPS-MSCs converged
toward MSCs (Figure S2C). Overall, gene expression pro-
files supported the notion that iPS-MSCs closely resemble
MSCs, even though there are differences in their immune
function.
DNA Methylation Profiles of iPS-MSCs
Subsequently, we have analyzed DNAm profiles of MSCs,
iPSCs, and iPS-MSCs (each of corresponding donors). Hier-
archical clustering demonstrated that iPS-MSCs and MSCs
cluster together (Figure 3A). At day 7 of differentiation to-
ward iPS-MSCs the methylome was between pluripotent
and nonpluripotent cells (Table S1). However, even after
5 weeks of differentiation 39,753 CpGs remained signifi-
cantly differentially methylated between iPS-MSCs and
MSCs (>20% differential DNAm; adjusted p value <0.01;
Table S2), whereas only 13,896 CpGs reached this level of
significance in iPS-MSCs versus iPSCs (Figure 3B). Overall,
DNAm levels were higher in iPSCs and iPS-MSCs as
compared to primaryMSCs. Nevertheless, redifferentiation
was associated with gradual loss of highly methylated and
gain of unmethylated CpG sites (Figure S3A). DNAm was
further analyzed in relevant genes – for example hyperme-
thylation of POU class 5 homeobox 1 (POU5F1; OCT3/4)
and Nanog homeobox gene (NANOG), and hypomethyla-
tion of surface marker genes NT5E (CD73) and endoglin
(ENG; CD105) (Figure 3C). Notably, these DNAm patterns
revealed high similarity between primary and redifferenti-
ated MSCs in many genes, particularly in NT5E. Compari-
son of DNAm changes with expression changes of corre-
sponding genes revealed some association, but there was
no universal linear correlation (Figures S3B and S3C).
Furthermore, DNAm differences of iPS-MSCs and MSCs
were enriched in intergenic regions and shore regions of
CpG islands (Figures 3D and S3D).
Comprehensive Analysis of DNAm Changes in
iPS-MSCs
We have recently demonstrated that iPSCs maintain
donor-specific characteristics in their DNAm pattern:
1,091 CpGs with the highest variation in different MSC
preparations remained methylated at similar level in corre-
sponding iPSCs (Shao et al., 2013). Here, we demonstrate
that this donor-specific pattern was also maintained upon
redifferentiation into iPS-MSCs (Figures 4A and S4A).Reports j Vol. 3 j 414–422 j September 9, 2014 j ª2014 The Authors 415
Figure 1. Generation of iPS-MSCs
(A) Phase contrast images of MSCs, iPSCs, and iPS-MSCs in the course of differentiation either with or without EB formation. Thirty-five
days after induction of differentiation, iPS-MSCs revealed similar fibroblastoid morphology as MSCs.
(B) Population doublings (PDs) of MSCs and iPS-MSCs within 6 days of culture on gelatin-coated plates (N = 3; n = 3; mean ± SD;
***p < 0.001).
(C) iPS-MSCs displayed similar immunophenotypic characteristics as primary MSCs (autofluorescence is indicated in gray).
(D) MSCs and iPS-MSCs were differentiated toward adipogenic, osteogenic, or chondrogenic lineages for three weeks and subsequently
stained with BODIPY/DAPI, alizarin red, or Alcian blue/PAS, respectively. Controls were simultaneously cultured in normal growth medium,
and representative images are presented.
(E) In vitro differentiation potential was further assessed by quantitative real-time PCR of adipogenic (ADIPOQ, FABP4), osteogenic
(RUNX2, SP7, COL1A1, SPARC), and chondrogenic (SOX9, ACAN, COL2A1) marker genes in MSCs (green) and iPS-MSCs (blue; N = 3; n = 2;
mean ± SD; *p < 0.05; **p < 0.01 versus nondifferentiated control).
See also Figure S1.
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Figure 2. Gene Expression Profiles of iPS-MSCs Are Similar to Primary MSCs
(A) Hierarchical clustering revealed close relationship of iPS-MSCs and primary MSCs. MSC donor number (‘‘M’’) and clone number (‘‘C’’) are
indicated for iPSCs and iPS-MSCs. Furthermore, passage numbers (‘‘P’’) are provided for MSCs and time of redifferentiation (‘‘d’’) for iPS-MSCs.
(B) Heatmap of pairwise correlation coefficients (R2) demonstrates relationship of iPS-MSCs and MSCs.
(C) Pluripotency was assessed by PluriTest analysis (Mu¨ller et al., 2011). After differentiation for more than 7 days toward iPS-MSCs, cells
were clearly associated with nonpluripotent samples (blue area) and not with pluripotent samples (red area; labeling of samples as in A).
(D) MSC marker genes were expressed at similar level in primary MSCs and iPS-MSCs.
(E) Number of differentially expressed genes between MSCs, iPSCs, and iPS-MSCs (>2-fold regulation; adjusted p value <0.01; for each cell
type, the number of upregulated genes is indicated by color code).
(F) Geneontology analysis of genes that aredifferentially expressedbetweenMSCs and iPS-MSCs. Themost significant categories are depicted.
(G) Activity of iPS-MSCs and MSCs on proliferation of stimulated CD4+ T cells was assessed by flow cytometry and carboxyfluorescein
succinimidyl ester (CFSE) staining. Different T cell:MSC ratios were used and representative histograms are depicted (unstimulated control
is indicated in light gray). The percentage of proliferating cells is indicated in each histogram.
(H) Quantitative analysis of T cell proliferation assay was performed with percentage of proliferated cells as shown in (G) (MSCs: N = 3;
iPS-MSCs: N = 2; mean ± SD; *p < 0.05; **p < 0.01).
See also Figure S2.
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Figure 3. DNAm Profiles of iPS-MSCs
(A) Hierarchical clustering of global DNAm profiles.
(B) Number of CpGs with differential DNAm between MSCs, iPSCs, and iPS-MSCs (>20% change in DNAm level; adjusted p value <0.01; for
each cell type hypermethylated CpGs are indicated by color code).
(C) DNAm levels (b values) of CpGs represented in the genes POU5F1 (OCT3/4), NANOG, NT5E (CD73), and ENG (CD105) (TSS1500: 1,500 bp
upstream of transcription start site; TSS200: 200 bp upstream of TSS; UTR).
(D) Enrichment of differential DNAm of MSCs versus iPS-MSCs in gene regions or in relation to CpG islands (p values were estimated by
hypergeometric distribution).
See also Figure S3.
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DNA Methylation in iPS-MSCsSubsequently, we analyzed if tissue-specific DNAm pat-
terns are reestablished in iPS-MSCs. We have previously
isolated MSCs from adipose tissue (AT) and bone marrow
(BM); the latter were either derived from iliac crest (iliac)
or caput femoris (hip): 1,711 CpGs revealed at least 15%
differential DNAm in AT-MSCs versus BM-MSCs (Schellen-
berg et al., 2011). These DNAm changes were most signifi-
cantly enriched in GO categories for nutrient level, lipid
modification, and glucose metabolism reflecting func-
tional differences of the originating tissues. Our MSCs
from tibia plateau (knee) clustered with the other BM-
MSCs. However, this tissue-specific DNAm pattern was
erased by reprogramming and not reestablished upon dif-
ferentiation toward iPS-MSCs (Figure 4B).
Long-term culture of MSCs is associated with highly
reproducible DNAm changes—enriched in the homeobox418 Stem Cell Reports j Vol. 3 j 414–422 j September 9, 2014 j ª2014 The Agene cluster (HOXB) and the keratin associated protein
(KRTAP) locus—which are almost entirely reversed in iPSCs
(Koch et al., 2013). Here, we demonstrate that these senes-
cence-associated DNAm changes are regained during cul-
ture expansion of iPS-MSCs. In particular CpGs, which are
hypomethylated during expansion of MSCs, were reversed
tohighDNAm levels in iPSCs and subsequently againhypo-
methylated during expansion of iPS-MSCs (Figure S4B).
Alternatively, we estimated cellular senescence by pyrose-
quencing of six senescence-associated CpGs (Koch et al.,
2012). This Epigenetic-Senescence-Signature provides a
biomarker that facilitates robust predictions for passage
numbers (Figure S4C) and cumulative population doublings
(Figures 4C and S4D): senescence predictions increased
continuously during differentiation toward iPS-MSCs and
after 35 days iPS-MSCs resembled MSCs of early passage inuthors
Figure 4. Donor-, Tissue-, and Age-Specific DNAm Changes
(A) Hierarchical cluster analysis of 1,091 CpGs with highest donor-specific variation in primary MSC preparations (SD > 0.2) (Shao et al.,
2013) revealed that iPSCs and iPS-MSCs clustered with their parental cell preparations. This indicates that interindividual DNAm patterns
are maintained in iPS-MSCs (*cultivated in mTeSR1).
(B) Hierarchical cluster analysis of 1,711 CpGs with differential DNAm in MSCs from adipose tissue (AT) and bone marrow (BM; >15%
difference in mean methylation level) (Schellenberg et al., 2011) demonstrated that the BM-associated DNAm pattern is erased in iPSCs
and not reestablished in iPS-MSCs.
(C) The state of cellular senescence was estimated by pyrosequencing analysis of six senescence-associated CpGs (Koch et al., 2012).
Predictions of this Epigenetic-Senescence-Signature for cumulative population doublings (cPD) were reversed upon reprogramming into
iPSCs and increased again during differentiation toward iPS-MSCs.
(D) To estimate the state of cellular senescence in iPS-MSCs we analyzed the frequency of fibroblastoid colony forming units (CFU-f). CFU-f
frequency declines continuously in primary BM-MSCs and AT-MSCs (Schellenberg et al., 2012) and the number of CFU-f in iPS-MSCs after
35 days is in line with culture expansion for five passages.
(E) Donor age of cell preparations was estimated using a multivariate model based on DNAm of 99 age-related CpGs of blood (Weidner et al.,
2014).
(F) Alternatively, donor age was predicted using a recently published predictor applicable for different tissues (Horvath, 2013). Overall,
epigenetic rejuvenation upon reprogramming into iPSCs is also maintained in iPS-MSCs.
See also Figure S4.
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DNA Methylation in iPS-MSCstheir epigenetic makeup. To gain further insight into the
state of cellular senescence of iPS-MSCs, we quantified the
frequency of fibroblastoid colony-forming units (CFU-f),
which rapidly declines during culture expansion of primary
MSCs (Schellenberg et al., 2012). In iPS-MSCs at day 35 (pas-
sage 5), about 5% of the cells were capable to form colonies,
which correspond to primaryMSCs at passage 5 (Figure 4D).
Aging of the organism is also associated with specific
DNAm changes, which are reversed upon reprogramming
into iPSCs (Horvath, 2013; Weidner et al., 2014). Here,
we analyzed whether these age-related DNAm changes
are restored in iPS-MSCs. To this end, we have used a set
of 99 CpGs, which reveal age-associated DNAm changes
in blood. A multivariate model based on these CpGs has
been used to estimate donor age (Weidner et al., 2014). In
fact, iPS-MSCs reflect moderate accumulation of age-
related DNAm but the samples were estimated much
younger than the MSC donors (Figure 4E). Similar results
were observed using the epigenetic predictor described by
Horvath, which is based onmore CpGs and which is appli-
cable to different tissues and cell types (Horvath, 2013)
(Figure 4F; correlation between the two predictors: R =
0.80). Overall, iPS-MSCs remained rejuvenated with regard
to their DNAm profiles.DISCUSSION
Induced pluripotent stem cells are a very good basis for
generation of standardized cell types. However, differentia-
tion to specific cell types remains a major challenge. Here,
we describe a simple protocol for differentiation of iPSCs
toward iPS-MSCs, which may be assisted by the fact that
our iPSCs were initially derived from MSCs. Furthermore,
the medium used for iPS-MSC induction is the same as
for initial culture isolation of MSCs. These culture condi-
tions would be compatible with guidelines of good
manufacturing practice (GMP) in cellular therapy. Our
iPS-MSCs fulfilled the minimal criteria of MSCs (Dominici
et al., 2006), but the propensity for adipogenic differentia-
tion was markedly decreased as compared to primary
MSCs. This has also been observed by several other groups
that used different protocols for generation of iPS-MSCs
(Boyd et al., 2009; Chen et al., 2012; Diederichs and
Tuan, 2014). Furthermore, adipogenic differentiation is
also quite heterogeneous within primary MSCs (Schellen-
berg et al., 2012). Hence, a more sophisticated molecular
definition is required for MSCs and for iPS-MSCs.
MSCs and iPS-MSCs revealed close relationship in gene
expression profiles. However, genes associated with T cell
activation and immune response were higher expressed in
MSCs. Consistent with these observations, iPS-MSCs were
impaired in suppressing T cell proliferation, indicating420 Stem Cell Reports j Vol. 3 j 414–422 j September 9, 2014 j ª2014 The Athat iPS-MSCs have lower immunomodulatory properties
than primary MSCs. Other authors indicated that ESC-
and iPSC-derived MSCs are somewhat immunoprivileged
and might even have therapeutic efficacy in autoimmune
disorder models (de Peppo et al., 2010; Fu et al., 2012;
Kimbrel et al., 2014). Therefore, the immunomodulatory
function of iPS-MSCs—which is critical for clinical applica-
tion—deserves further analysis in future studies.
Gene expression changes are not necessarily reflected
on DNAm level and vice versa. In fact, many recent
studies demonstrated no general correlation of DNAm
and gene expression (Wagner et al., 2014), despite the com-
mon perception of hypermethylation in promoter re-
gions should entail downregulation of gene expression.
Although our understanding of the functional relevance
of specific DNAm changes is so far limited epigenetic
profiles are very well suited to classify cell preparations:
DNAm can be provided as absolute b values at single base
resolution; it is relatively stable; less prone to growth con-
ditions; and less influenced by subpopulations, which
may highly overexpress subsets of genes. In this regard,
the large number of differentially methylated CpGs indi-
cates that iPS-MSCs are rather ‘‘MSC-like’’ than direct corre-
lates of primary MSCs—this has to be taken into account,
but it does not exclude that iPS-MSCsmay be valuable tools
for cellular therapy, too.
We have demonstrated that donor-specific DNAm pat-
terns are maintained upon reprogramming into iPSCs
(Shao et al., 2013), and these also remain upon rediffer-
entiation into iPS-MSCs. Thus, there is some epigenetic
memory after chromatin remodeling—whether these
donor-specific DNAm patterns are functionally relevant
remains to be elucidated. On the other hand, tissue-specific
epigenetic differences were erased during reprogramming
and not reestablished in iPS-MSCs. This may explain
some of the epigenetic discrepancy of MSCs and iPS-MSCs.
DNAm changes that accumulate during in vitro culture of
MSCs (Koch et al., 2013) are also induced at a similar level
during culture expansion of iPS-MSCs—apparently starting
with loss of the pluripotent state. In contrast, age-related
DNAm, which accumulates during aging of the organism
(Weidner et al., 2014; Horvath, 2013) remains overall reset
in iPS-MSCs. Notably, epigenetic rejuvenation does not
counteract mutations, which may accumulate during
invitroculture. So far, the functional relevanceof age-related
DNAm changes and the underlying mechanism are not
known, but the finding that they remain reset in iPS-MSCs
is interesting and encourages further comparison with
MSCs from different aged donors in vitro and in vivo. If
age-related modifications contribute to loss of regenerative
potential this may suggest higher regenerative potential of
iPS-MSCs, which may also be reflected by the higher prolif-
eration rates of iPS-MSCs as compared to primary MSCs.uthors
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DNA Methylation in iPS-MSCsTaken together, we described a simple one-step protocol
to redifferentiate MSC-derived iPSCs toward MSCs. These
iPS-MSCs reveal similar morphology, immunophenotype,
and in vitro differentiation potential as primary MSCs;
yet, there are marked differences in DNAm profiles that
can, at least partially, be attributed to persistent reset of
tissue-specific and age-related DNAm changes. In this re-
gard, iPS-MSCs seem to provide more standardized cell
products than primary MSCs, but the therapeutic effi-
ciency—particularly with regard to their immunomodula-
tory functions—needs to be critically assessed.EXPERIMENTAL PROCEDURES
A detailed description of all materials and methods is presented in
the Supplemental Experimental Procedures.
Generation of iPS-MSCs
MSCs were isolated from bone marrow and reprogrammed in to
iPSCs as described previously (Shao et al., 2013) (Table S3). For re-
differentiation of iPSCs toward iPS-MSCs, we used two alternative
strategies: (1) medium was simply exchanged for MSC standard
medium with 10% hPL for 7 days, and cells were then further
passaged in culturewells with 0.1%gelatin (Sigma-Aldrich) or non-
coated plates, or (2) EBs were generated for 7 days in ultralow
attachment plates (Corning) and then cultured on either gelatin-
coated or noncoated plates.
Gene Expression Analysis
Gene expression profiles were analyzed by GeneChip Human
Gene 1.0 ST Array (Affymetrix).
DNA Methylation Analysis
DNAmprofiles were analyzed using the InfiniumHumanMethyla-
tion450 BeadChip (Illumina), which addresses 485,577 CpG dinu-
cleotides at a single-nucleotide resolution.
Statistical Analysis
Results are provided as mean ± SD of at least three independent
experiments if not otherwise stated, and Student’s t test was adop-
ted to estimate statistical significance. ‘‘N’’ indicates the number of
independent experiments, whereas ‘‘n’’ provides the number of
technical replicates within the same experiment.
ACCESSION NUMBERS
Gene expression and DNAm data have been deposited at NCBI’s
Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/)
under accession numbers GSE54766, GSE38806, GSE46019 (gene
expression) and GSE54767, GSE34688, GSE26519, GSE17448
(DNAm).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, and three tables and can be foundStem Cellwith this article online at http://dx.doi.org/10.1016/j.stemcr.
2014.07.003.
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